BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 24372901)

  • 1. 'Real-world' effectiveness of smoking cessation treatments: a population study.
    Kotz D; Brown J; West R
    Addiction; 2014 Mar; 109(3):491-9. PubMed ID: 24372901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderators of real-world effectiveness of smoking cessation aids: a population study.
    Jackson SE; Kotz D; West R; Brown J
    Addiction; 2019 Sep; 114(9):1627-1638. PubMed ID: 31117151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effectiveness of varenicline and combination nicotine replacement therapy for smoking cessation in clinical practice.
    Brose LS; West R; Stapleton JA
    Mayo Clin Proc; 2013 Mar; 88(3):226-33. PubMed ID: 23489449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
    Cahill K; Stevens S; Perera R; Lancaster T
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD009329. PubMed ID: 23728690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between use of pharmacological aids in a smoking cessation attempt and subsequent quitting activity: a population study.
    Ferguson SG; Brown J; Frandsen M; West R
    Addiction; 2015 Mar; 110(3):513-8. PubMed ID: 25393225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
    Bailey SR; Crew EE; Riske EC; Ammerman S; Robinson TN; Killen JD
    Paediatr Drugs; 2012 Apr; 14(2):91-108. PubMed ID: 22248234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of use and real-world effectiveness of smoking cessation aids during the COVID-19 pandemic: a representative study of smokers in England.
    Jackson SE; Cox S; Shahab L; Brown J
    Addiction; 2022 Sep; 117(9):2504-2514. PubMed ID: 35491743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey.
    Kasza KA; Hyland AJ; Borland R; McNeill AD; Bansal-Travers M; Fix BV; Hammond D; Fong GT; Cummings KM
    Addiction; 2013 Jan; 108(1):193-202. PubMed ID: 22891869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of varenicline versus nicotine replacement therapy for smoking cessation with minimal professional support: evidence from an English population study.
    Kotz D; Brown J; West R
    Psychopharmacology (Berl); 2014 Jan; 231(1):37-42. PubMed ID: 23873417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very low rate and light smokers: smoking patterns and cessation-related behaviour in England, 2006-11.
    Kotz D; Fidler J; West R
    Addiction; 2012 May; 107(5):995-1002. PubMed ID: 22126678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective cohort study of the effectiveness of varenicline versus nicotine replacement therapy for smoking cessation in the "real world".
    Kotz D; Brown J; West R
    BMC Public Health; 2014 Nov; 14():1163. PubMed ID: 25392075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective cohort study of the effectiveness of smoking cessation treatments used in the "real world".
    Kotz D; Brown J; West R
    Mayo Clin Proc; 2014 Oct; 89(10):1360-7. PubMed ID: 25282429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions to increase adherence to medications for tobacco dependence.
    Hollands GJ; Naughton F; Farley A; Lindson N; Aveyard P
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD009164. PubMed ID: 31425618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation.
    Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009670. PubMed ID: 23235680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.
    Stead LF; Koilpillai P; Lancaster T
    Cochrane Database Syst Rev; 2015 Oct; (10):CD009670. PubMed ID: 26457723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Abstinence rates with varenicline compared to bupropion and nicotine replacement therapy for quitting smoking in primary care].
    Sicras Mainar A; Navarro Artieda R; Díaz Cerezo S; Martí Sánchez B; Sanz De Burgoa V
    Aten Primaria; 2011 Sep; 43(9):482-9. PubMed ID: 21382649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
    Doggrell SA
    Expert Opin Pharmacother; 2007 Dec; 8(17):2903-15. PubMed ID: 18001252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.